SARS-CoV-2 cellular and humoral responses in vaccine-naive individuals during the first two waves of COVID-19 infections in the southern region of The Netherlands: a cross-sectional population-based studyResearch Article Published on 2024-06-302024-09-05 Journal: Microbiology Spectrum [Category] update2024, [키워드] Antibody Response cellular immunity ELISPOT IFNγ response Peripheral blood mononuclear cell SARS-CoV-2 [DOI] 10.1128/spectrum.00126-24 PMC 바로가기 [Article Type] Research Article
Epitope mapping and a candidate vaccine design from canine distemper virusOriginal Research Published on 2024-04-302024-09-05 Journal: Open veterinary journal [Category] update2024, [키워드] CDV ELISPOT hemagglutinin peptides Vaccine [DOI] 10.5455/OVJ.2024.v14.i4.9 PMC 바로가기 [Article Type] Original Research
Evaluation of T Cell Response to SARS-CoV-2 in Kidney Transplant Recipients Receiving Monoclonal Antibody Prophylaxis and the Utility of a Bivalent mRNA Vaccine Booster DoseArticle Published on 2024-04-022024-09-05 Journal: Microorganisms [Category] update2024, [키워드] belatacept Cellular immune response COVID-19 ELISPOT Kidney transplantation [DOI] 10.3390/microorganisms12040722 PMC 바로가기 [Article Type] Article
Routine evaluation of HBV-specific T cell reactivity in chronic hepatitis B using a broad-spectrum T-cell epitope peptide library and ELISpot assayResearch Published on 2024-03-112024-09-05 Journal: Journal of Translational Medicine [Category] update2024, [키워드] antigen-specific T cell Chronic Hepatitis B ELISPOT T-cell epitopes [DOI] 10.1186/s12967-024-05062-5 PMC 바로가기 [Article Type] Research
Lymphocyte Function at Baseline Could Be a New Predictor of Tumor Burden following Six Cycles of Radium-223 Therapy in Patients with Metastasized, Castration-Resistant Prostate CancerArticle Published on 2024-02-222024-09-05 Journal: Cancers [Category] update2024, [키워드] antimicrobial immune response ELISPOT interferon-γ interleukin-10 Lymphocyte proliferation prediction of tumor burden radium-223 therapy [DOI] 10.3390/cancers16050886 PMC 바로가기 [Article Type] Article
Persistence of T-Cell Immunity Responses against SARS-CoV-2 for over 12 Months Post COVID-19 Infection in Unvaccinated Individuals with No Detectable IgG AntibodiesArticle Published on 2023-11-272024-09-05 Journal: Vaccines [Category] update2024, [키워드] cellular immunity coronavirus COVID-19 ELISPOT IFN-γ IGRA natural infection SARS-CoV-2 T-cell immunity vaccination [DOI] 10.3390/vaccines11121764 PMC 바로가기 [Article Type] Article
The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatmentHepatitis Published on 2023-09-132024-09-05 Journal: Emerging Microbes & Infections [Category] update2024, [키워드] Chronic HBV ELISPOT HBsAb HBsAb-specific B cells HBsAg seroconversion Peg-IFN-α treatment [DOI] 10.1080/22221751.2023.2259003 PMC 바로가기 [Article Type] Hepatitis
Interferon-gamma FlowSpot assay for the measurement of the T-cell response to cytomegalovirusResearch Article Published on 2023-06-082024-09-05 Journal: Heliyon [Category] update2024, [키워드] CMV-Specific T-cells ELISPOT FlowSpot IFN-γ serologic analysis [DOI] 10.1016/j.heliyon.2023.e16792 PMC 바로가기 [Article Type] Research Article
Immunogenicity and reactogenicity of SARS-CoV-2 vaccines in people living with HIV in the Netherlands: A nationwide prospective cohort studyArticle Published on 2022-10-272022-11-15 Journal: PLoS Medicine [Category] COVID19(2023년), SARS, 진단, [키워드] 95% CI Ad26.COV2.S Ad26.COV2.S vaccine age Analysis anti-SARS-CoV-2 Anti-spike antibody Antibody Response Antiretroviral therapy approved assays BNT162b2 CD4+ T-cell CD8+ T-cell ChAdOx1-S comparable Concentration conducted Control controls COVID-19 defined ELISPOT Endpoint Environment Final generally mild geometric HIV HIV-negative IFN-γ immunogenic immunogenicity Increased IQR less maintain male marker median age mRNA vaccination mRNA vaccine mRNA-1273 mRNA-based vaccines Netherland Netherlands of BNT162b2 PLWH predicted primary endpoint prospective cohort study Public reactogenicity receiving recipients reduced Registered remained required response SARS-CoV-2 antibody SARS-CoV-2 IgG SARS-CoV-2 spike peptide SARS-CoV-2 vaccination SARS-CoV-2 vaccine secondary Serious Adverse Events serological response Sex suppressed T-cell Response the median the vaccine Trial vaccination Vaccine vaccine group Viral load with HIV [DOI] 10.1371/journal.pmed.1003979 PMC 바로가기
Divergent SARS-CoV-2-specific T cell responses in intensive care unit workers following mRNA COVID-19 vaccinationArticle Published on 2022-10-062022-11-15 Journal: Frontiers in Immunology [Category] COVID19(2023년), SARS, 진단, [키워드] acute respiratory syndrome analyzed antibody CD4 CD4+ CD4+ T cells CD8 CD8+ CD8+ T cells Cellular immune response competent coronavirus COVID-19 COVID-19 vaccination develop dose elicited ELISPOT exhibited had no healthy individuals humoral ICU immune protection immune response individual individuals information intensive care intensive care unit workers lack maintain mRNA mRNA COVID-19 vaccines mRNA vaccine neutralizing antibody proportion Protein protein S reactive receiving reduction in SARS-CoV-2 SARS-CoV-2-specific T cell Seroconversion seronegative Specific T-cell response susceptibility T cell T cell response T cells T lymphocyte T-cell the S protein the SARS-CoV-2 the spike protein vaccination viral infection Viral protein [DOI] 10.3389/fimmu.2022.942192 PMC 바로가기